IP Verse

Samsung Bioepis Co., Ltd. vs Alexion Pharmaceuticals, Inc. et al.

The detailed information for PTAB case with proceeding number IPR2023-01069 filed by Samsung Bioepis Co., Ltd. against Alexion Pharmaceuticals, Inc. et al. on Jun 16, 2023. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2023-01069
Filing Date
Jun 16, 2023
Petitioner
Samsung Bioepis Co., Ltd.
Respondent
Alexion Pharmaceuticals, Inc. et al.
Status
Terminated-Settled
Respondent Application Number
15642096
Respondent Tech Center
1600
Respondent Patent Number
10590189
Institution Decision Date
Dec 20, 2023
Termination Date
Sep 4, 2024

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.


Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

Termination Decision: Post-DI Settlement

Sep 4, 2024PAPERBOARD

Joint Motion to Terminate

Aug 30, 2024PAPERPATENT OWNER

EX2109

Aug 30, 2024EXHIBITPATENT OWNER

Joint Motion to Treat Settlement Agreement as Confidential

Aug 30, 2024PAPERPATENT OWNER

ORDER Setting Oral Argument

Aug 26, 2024PAPERBOARD

Patent Owner's Request for Oral Argument

Aug 7, 2024PAPERPATENT OWNER

Petitioner's Request for Oral Hearing

Aug 7, 2024PAPERPETITIONER

Patent Owner's Updated Exhibit List

Jul 29, 2024PAPERPATENT OWNER

Patent Owner's Sur-Reply

Jul 29, 2024PAPERPATENT OWNER

2108 - 2024.07.16 Jeffrey Ravetch Deposition Transcript (FULL)

Jul 29, 2024EXHIBITPATENT OWNER

Notice of Deposition of J. Ravetch, M.D., Ph.D.

Jul 11, 2024PAPERPATENT OWNER

SECOND MODIFIED SCHEDULING ORDER 37 C.F.R. § 42.5(c)

Jul 9, 2024PAPERBOARD

Exhibit 3005

Jul 9, 2024EXHIBITBOARD

Stipulation Modifying Due Dates

Jul 8, 2024PAPERPATENT OWNER

Petitioner's Reply ISO Petition

Jun 10, 2024PAPERPETITIONER

Petitioner's Updated Exhibit List

Jun 10, 2024PAPERPETITIONER

Deposition of Arturo Casadevall, January 24, 2020

Jun 10, 2024EXHIBITPETITIONER

Reply Declaration of Jeffrey V. Ravetch, M.D., Ph.D.

Jun 10, 2024EXHIBITPETITIONER

Joint Stipulation Modifying Due Dates

May 14, 2024PAPERPETITIONER

2006 - Dmytrijuk

Mar 13, 2024EXHIBITPATENT OWNER

2014 - Greenspan

Mar 13, 2024EXHIBITPATENT OWNER

2023 - Arturo Casadevall MD PhD CV

Mar 13, 2024EXHIBITPATENT OWNER

2025 - CV Bernhardt Trout 504

Mar 13, 2024EXHIBITPATENT OWNER

2028 - Hill 2007

Mar 13, 2024EXHIBITPATENT OWNER

2029 - 1997 FDA Pts to Consider MAbs

Mar 13, 2024EXHIBITPATENT OWNER

2030 - Alexion Press Release 3-16-2007

Mar 13, 2024EXHIBITPATENT OWNER

2031 - Janeway Appx 2005

Mar 13, 2024EXHIBITPATENT OWNER

2033 - Kim 2005

Mar 13, 2024EXHIBITPATENT OWNER

2034 - Hwang 2005

Mar 13, 2024EXHIBITPATENT OWNER

2035 - Shepherd Appx 2000

Mar 13, 2024EXHIBITPATENT OWNER

2036 - Lo 2004

Mar 13, 2024EXHIBITPATENT OWNER

2037 - Welt 2003

Mar 13, 2024EXHIBITPATENT OWNER

2038 - Haller 2008

Mar 13, 2024EXHIBITPATENT OWNER

2039 - Torres 2007 PLOS Article

Mar 13, 2024EXHIBITPATENT OWNER

2040 - Torres 2005

Mar 13, 2024EXHIBITPATENT OWNER

2042 - Mathiew 2004

Mar 13, 2024EXHIBITPATENT OWNER

2043 - Andersen 2004

Mar 13, 2024EXHIBITPATENT OWNER

2044 - Chadd 2001

Mar 13, 2024EXHIBITPATENT OWNER

2045 - 2007 USP Dictionary of USAN and Int'l Drug Names

Mar 13, 2024EXHIBITPATENT OWNER

2046 - 1997 INN Naming Guidelines

Mar 13, 2024EXHIBITPATENT OWNER

2047 - McClean 2005

Mar 13, 2024EXHIBITPATENT OWNER

2049 - HemeOnc Today

Mar 13, 2024EXHIBITPATENT OWNER

2050 - Fatimah 2016

Mar 13, 2024EXHIBITPATENT OWNER

2051 - Foote 1992

Mar 13, 2024EXHIBITPATENT OWNER

2052 - Xiang 1995

Mar 13, 2024EXHIBITPATENT OWNER

2053 - Soliris Current Label (06-2019 Label)

Mar 13, 2024EXHIBITPATENT OWNER

2054 - Alexion Press Release 9-20-2006

Mar 13, 2024EXHIBITPATENT OWNER

2055 - Alexion Press Release 9-26-2006

Mar 13, 2024EXHIBITPATENT OWNER

2075 - GenScript Final Report

Mar 13, 2024EXHIBITPATENT OWNER

2079 - Chang 2002

Mar 13, 2024EXHIBITPATENT OWNER

2080 - Wang 1999

Mar 13, 2024EXHIBITPATENT OWNER

2081 - Hermeling 2004

Mar 13, 2024EXHIBITPATENT OWNER

2082 - Frokjaer

Mar 13, 2024EXHIBITPATENT OWNER

2083 - Rosenberg 2006

Mar 13, 2024EXHIBITPATENT OWNER

2084 - ICH Topic Q5C

Mar 13, 2024EXHIBITPATENT OWNER

2085 - Q1AR2 Stability Testing Guidance

Mar 13, 2024EXHIBITPATENT OWNER

2086 - Stebbings 2013

Mar 13, 2024EXHIBITPATENT OWNER

2088 - Amgen Biosimilar Pipeline

Mar 13, 2024EXHIBITPATENT OWNER

2089 - Generium Elizaria

Mar 13, 2024EXHIBITPATENT OWNER

2090 - Samsung Bisolimilar Pipeline

Mar 13, 2024EXHIBITPATENT OWNER

2091 - Harlowe and Lane 1988

Mar 13, 2024EXHIBITPATENT OWNER

2104 - 2024.02.23 Jeffrey Ravetch Deposition Transcript (FULL)

Mar 13, 2024EXHIBITPATENT OWNER

2105 - Declaration of A. Casadevall (for POR) FINAL [189]

Mar 13, 2024EXHIBITPATENT OWNER

2106 - 2024.02.20 Cindy Ippoliti Deposition Transcript (FULL)

Mar 13, 2024EXHIBITPATENT OWNER

2107 - Declaration of B. Trout (for POR) FINAL [189]

Mar 13, 2024EXHIBITPATENT OWNER

Patent Owner Response

Mar 13, 2024PAPERPATENT OWNER

EXPUNGED

Feb 12, 2024EXHIBITBOARD

FIRST MODIFIED SCHEDULING ORDER

Feb 12, 2024PAPERBOARD

Ex 3004

Feb 12, 2024EXHIBITBOARD

Patent Owner's Notice of Deposition of Cindy Ippoliti, Pharm.D.

Feb 7, 2024PAPERPATENT OWNER

Patent Owner's Notice of Deposition of Jeffrey V. Ravetch, M.D., Ph.D.

Feb 7, 2024PAPERPATENT OWNER

Institution Decision: DECISION Institution of Inter Partes Review 35 U.S.C. § 314(a)

Dec 20, 2023PAPERBOARD

Patent Owner's Sur-Reply to Petitioner's Reply to Preliminary Response

Dec 1, 2023PAPERPATENT OWNER

US10703809

Nov 15, 2023EXHIBITBOARD

EXPUNGED

Nov 15, 2023EXHIBITBOARD

Petitioner's Reply to Patent Owner's Preliminary Response

Nov 10, 2023PAPERPETITIONER

Ex. 3001

Oct 19, 2023EXHIBITBOARD

Patent Owner Preliminary Response

Oct 13, 2023PAPERPATENT OWNER

2005 - SOLIRIS Label

Oct 13, 2023EXHIBITPATENT OWNER

2007 - Janeway and Travers

Oct 13, 2023EXHIBITPATENT OWNER

2008 - McCloskey

Oct 13, 2023EXHIBITPATENT OWNER

2009 - Torres

Oct 13, 2023EXHIBITPATENT OWNER

2010 - Janda

Oct 13, 2023EXHIBITPATENT OWNER

2011 - Pritsch 1996

Oct 13, 2023EXHIBITPATENT OWNER

2012 - Pritsch 2000

Oct 13, 2023EXHIBITPATENT OWNER

2013 - McLean

Oct 13, 2023EXHIBITPATENT OWNER

2015 - Radbruch

Oct 13, 2023EXHIBITPATENT OWNER

2017 - Hawkins

Oct 13, 2023EXHIBITPATENT OWNER

2018 - Alexion Pharmaceuticals Form 10K

Oct 13, 2023EXHIBITPATENT OWNER

2019 - Ricklin and Lambris

Oct 13, 2023EXHIBITPATENT OWNER

2020 - Alexion Press Release

Oct 13, 2023EXHIBITPATENT OWNER

2021 - Alexion BusinessWire

Oct 13, 2023EXHIBITPATENT OWNER

2022 - Arturo Casadevall Declaration

Oct 13, 2023EXHIBITPATENT OWNER

2024 - Bernhardt L. Trout PhD Declaration

Oct 13, 2023EXHIBITPATENT OWNER

2026 - Michel Nussenzweig Declaration

Oct 13, 2023EXHIBITPATENT OWNER

2098 - Harlow and Lane Chapter 1

Oct 13, 2023EXHIBITPATENT OWNER

2100 - Rother 2007

Oct 13, 2023EXHIBITPATENT OWNER

2101 - [1002] - Part 1 - Prosecution History for US Patent 9,718,880

Oct 13, 2023EXHIBITPATENT OWNER

2101 - [1002] - Part 2 - Prosecution History for US Patent 9,718,880

Oct 13, 2023EXHIBITPATENT OWNER

2103 - [1002] - Prosecution History for US Patent No. 9,725,504 B2

Oct 13, 2023EXHIBITPATENT OWNER

NOTICE OF FILING DATE ACCORDED TO PETITION AND TIME FOR FILING PATENT OWNER PRELIMINARY RESPONSE

Jul 14, 2023PAPERBOARD

Notice : Mandatory Notice

Jul 6, 2023PAPERPATENT OWNER

Notice : Power of Attorney

Jul 6, 2023PAPERPATENT OWNER

Notice : Power of Attorney

Jun 16, 2023PAPERPETITIONER

Petition : as filed

Jun 16, 2023PAPERPETITIONER

U.S. Patent No. 10,590,189 B2 issued to Leonard Bell et al.

Jun 16, 2023EXHIBITPETITIONER

Part 1 - Prosecution History for U.S. Patent No. 10,590,189 B2

Jun 16, 2023EXHIBITPETITIONER

Part 2 - Prosecution History for U.S. Patent No. 10,590,189 B2

Jun 16, 2023EXHIBITPETITIONER

Part 3 - Prosecution History for U.S. Patent No. 10,590,189 B2

Jun 16, 2023EXHIBITPETITIONER

Part 4 - Prosecution History for U.S. Patent No. 10,590,189 B2

Jun 16, 2023EXHIBITPETITIONER

Part 5 - Prosecution History for U.S. Patent No. 10,590,189 B2

Jun 16, 2023EXHIBITPETITIONER

Part 6 - Prosecution History for U.S. Patent No. 10,590,189 B2

Jun 16, 2023EXHIBITPETITIONER

Part 7 - Prosecution History for U.S. Patent No. 10,590,189 B2

Jun 16, 2023EXHIBITPETITIONER

Part 8 - Prosecution History for U.S. Patent No. 10,590,189 B2

Jun 16, 2023EXHIBITPETITIONER

Part 9 - Prosecution History for U.S. Patent No. 10,590,189 B2

Jun 16, 2023EXHIBITPETITIONER

Part 10 - Prosecution History for U.S. Patent No. 10,590,189 B2

Jun 16, 2023EXHIBITPETITIONER

Part 11 - Prosecution History for U.S. Patent No. 10,590,189 B2

Jun 16, 2023EXHIBITPETITIONER

Part 12 - Prosecution History for U.S. Patent No. 10,590,189 B2

Jun 16, 2023EXHIBITPETITIONER

Part 13 - Prosecution History for U.S. Patent No. 10,590,189 B2

Jun 16, 2023EXHIBITPETITIONER

Part 14 - Prosecution History for U.S. Patent No. 10,590,189 B2

Jun 16, 2023EXHIBITPETITIONER

Declaration of Jeffrey V. Ravetch, M.D., Ph.D.

Jun 16, 2023EXHIBITPETITIONER

U.S. Pat. Appl. Publ. No. 2003/0232972 A1 issued to Katherine S. Bowdish

Jun 16, 2023EXHIBITPETITIONER

U.S. Patent No. 6,355,245 B1 issued to Mark J. Evans et al.

Jun 16, 2023EXHIBITPETITIONER

Mueller, et al., Humanized Porcine VCAM-Specific...34 M.Imm. 441 (1997)

Jun 16, 2023EXHIBITPETITIONER

U.S. Pat. Appl. Publ. No. 2005/0191298 A1 issued to Leonard Bell et al.

Jun 16, 2023EXHIBITPETITIONER

Tacken, Effective induction of naive and recall..., 106 Blood 1278 (2005)

Jun 16, 2023EXHIBITPETITIONER

WO 97/11971 issued to John P. Mueller et al.

Jun 16, 2023EXHIBITPETITIONER

Thomas, Inhibition of Complement Activity..., 33 M.Imm. 1389 (1996)

Jun 16, 2023EXHIBITPETITIONER

Hillmen, Effect of Eculizumab..., 305 N.Engl.J.Med. 552 (2004)

Jun 16, 2023EXHIBITPETITIONER

Hill, Abstract #2823...104 Blood 772a (2004)

Jun 16, 2023EXHIBITPETITIONER

Hill, Sustained response..., 106 Blood 2559 (2005)

Jun 16, 2023EXHIBITPETITIONER

Hillmen, The Complement Inhibitor..., 355 N.Engl.J.Med, 1233 (2006)

Jun 16, 2023EXHIBITPETITIONER

Young, Abstract # 971...., 108 Blood 290a (2006)

Jun 16, 2023EXHIBITPETITIONER

Hillmen, Abstract #154..., 100 Blood 44a (2002)

Jun 16, 2023EXHIBITPETITIONER

Hillmen, Abstract #1858...., 102 Blood 590a (2003)

Jun 16, 2023EXHIBITPETITIONER

Excerpts from Recommended INN ..., 17 WHO Drug Info 115, WHO (2003)

Jun 16, 2023EXHIBITPETITIONER

Guidelines...INN..., Div. Drug Management & Policies, WHO, Geneva (1997)

Jun 16, 2023EXHIBITPETITIONER

Alexion Press Rel., Alexion Issued Key C5....(Mar. 15, 2002)

Jun 16, 2023EXHIBITPETITIONER

WO 2005/007809 A2 issued to Russell P. Rother, et al.

Jun 16, 2023EXHIBITPETITIONER

WO 2005/110481 A2 issued to Russell P. Rother, et al.

Jun 16, 2023EXHIBITPETITIONER

Kaplan, Eculizumab Alexion, 3 Curr. Opin. Investig. Drugs 1017 (2002)

Jun 16, 2023EXHIBITPETITIONER

Amgen v. Alexion, IPR2019-00739, #15, Decision - Inst of IPR 8/30/2019

Jun 16, 2023EXHIBITPETITIONER

Amgen v. Alexion, IPR2019-00739, #22, PO Response 11/22/2019

Jun 16, 2023EXHIBITPETITIONER

Amgen v. Alexion, IPR2019-00739, #48, Termination 6/1/2020

Jun 16, 2023EXHIBITPETITIONER

Opposition File History for EP 1 720 571 B1

Jun 16, 2023EXHIBITPETITIONER

File History for P 3 167 888

Jun 16, 2023EXHIBITPETITIONER

Excerpt from File History of US Pat Appl 11/127,438 - Amdmt to Resp 8/2/11

Jun 16, 2023EXHIBITPETITIONER

Appl. for Extension of Patent Term US Pat 6,355,245

Jun 16, 2023EXHIBITPETITIONER

Certificate Extending Patent Term, US Pat No. 6,355,245 6/11/2010

Jun 16, 2023EXHIBITPETITIONER

Yoo, Human IgG2...170 J. Immunol. 3134 (2003)

Jun 16, 2023EXHIBITPETITIONER

Wypych, Human IgG2....283 J. Biol. Chem. 16194 (2008)

Jun 16, 2023EXHIBITPETITIONER

Bournazos, Fc-optimized antibodies..., 588 Nature 485 (2020)

Jun 16, 2023EXHIBITPETITIONER

Bournazos, Human IgG Fc domain...124 J. Clinical Investigation 725 (2014)

Jun 16, 2023EXHIBITPETITIONER

Baudino, Impact of a Three Amino..., 181 J. Immunology 4107 (2008)

Jun 16, 2023EXHIBITPETITIONER

Takai, FcR Y Chain Deletion...., 76 Cell 519 (1994)

Jun 16, 2023EXHIBITPETITIONER

Nimmerjahn, Fcy receptors...., 8 Nat. Rev. Immunol. 34 (2008)

Jun 16, 2023EXHIBITPETITIONER

Ravetch, Fc Receptors, 9 Annu. Rev. Immunol. 457 (1991)

Jun 16, 2023EXHIBITPETITIONER

US Pat Appl Publ No. 2005/0271660 A1 issued to Yi Wang

Jun 16, 2023EXHIBITPETITIONER

Janeway, Chapter 1...Chapter 3, Immunobio: .. 1-34, 93-122 (5th ed. 2001)

Jun 16, 2023EXHIBITPETITIONER

Excerpts from Juo, Concise Dict. Biomed & Molecular Biol (2d ed. 2001)

Jun 16, 2023EXHIBITPETITIONER

Volkel, Optimized Linker ..., 14 Protein Engineering 815 (2001)

Jun 16, 2023EXHIBITPETITIONER

Lobo, Antibody Pharmacokinetics...93 J. of Pharma. Sciences 2645 (2004)

Jun 16, 2023EXHIBITPETITIONER

Lipman, Monoclonal Versus Polyclonal...46 ILAR J. 258 (2005)

Jun 16, 2023EXHIBITPETITIONER

Lo, C.7, Antibody....Methods in Molecular Bio, V.248...135-159 (2004)

Jun 16, 2023EXHIBITPETITIONER

Riechmann, Reshaping human antibodies for therapy, 332 Nature 323 (1988)

Jun 16, 2023EXHIBITPETITIONER

Reichert, Marketed therapeutic antibodies compendium, 4 mAbs 413 (2012)

Jun 16, 2023EXHIBITPETITIONER

Alberts, Chapter 12....Molecular Bio of the Cell, pp. 551-98 (1994)

Jun 16, 2023EXHIBITPETITIONER

Adderson, Immunoglobulin Light Chain...89 J. Clin. Invest. 729 (1992)

Jun 16, 2023EXHIBITPETITIONER

Genentech, Avastin 2004 Package Insert

Jun 16, 2023EXHIBITPETITIONER

Millenniumm, Campath 2001 Package Insert

Jun 16, 2023EXHIBITPETITIONER

ImClone Systems, Inc., Erbitux 2004 Package Insert

Jun 16, 2023EXHIBITPETITIONER

Genentech, Herceptin 1998 Package Insert

Jun 16, 2023EXHIBITPETITIONER

Centocor, Remicade 1998 Package Insert

Jun 16, 2023EXHIBITPETITIONER

Genentech, Rituxan 1997 Package Insert

Jun 16, 2023EXHIBITPETITIONER

Daugherty, Formulation and delivery...58 Adv. Drug Delivery Rev. 686 (2006)

Jun 16, 2023EXHIBITPETITIONER

Declaration of Cindy Ippoliti, Pharm.D.

Jun 16, 2023EXHIBITPETITIONER

Note for Guidance on Excipients, Antioxidants and Antimicrobial...(2003)

Jun 16, 2023EXHIBITPETITIONER

Excerpt from File History Pat. No. 9,718,880, Resp to NonFinal 5/12/2017

Jun 16, 2023EXHIBITPETITIONER